SGN-00101 (HspE7) Immunotherapy Of CIN III
Latest Information Update: 03 Nov 2021
At a glance
- Drugs Verpasep caltespen (Primary)
- Indications Cervical intraepithelial neoplasia
- Focus Adverse reactions; Therapeutic Use
- 06 Mar 2007 Results have been reported.
- 06 Mar 2007 Status change from recruiting to completed
- 20 Nov 2005 New trial record.